Ureteroscopic Lithotripsy for Renal Stones Using a Sheathless Approach or Using a Flexible and Navigable Ureteral Access Sheath (FANS)
FANS vs Sheathless URS Lithotripsy - a Prospective, Randomised Clinical Trial
1 other identifier
interventional
225
1 country
1
Brief Summary
The primary aim of the study is to compare stone free rates following ureteroscopic (URS) lithotripsy for renal stones with Thulium Fiber Laser (TFL) using a sheathless approach (low power laser settings) or using a flexible and navigable ureteral access sheath (FANS) with either low power or high power laser settings. Secondary aims are to compare the results of sheathless- and FANS assisted URS lithotripsy in terms of operative time, laser time, intraoperative and postoperative complications. Following the primary comparison between sheathless and FANS groups, another aim is to compare the outcome of low power and high power URS lithotripsy in the FANS patients with respect to operative time, SFR, laser time, intraoperative and postoperative complications. Patients ≥ 18 years with renal stones (8-25 mm) scheduled for URS lithotripsy at the Day Surgery Clinic at Haukeland University Hospital in Bergen, Akershus University Hospital and The Hospital of Vestfold - all renal stone centres in Norway, are eligible for inclusion in the study. After written consent and inclusion, patients are randomised to laser lithotripsy using one of three alternative ureteroscopic approaches: Group 1: Sheathless URS using low power TFL 4 -10 Watts, short pulse mode, Group 2: URS with FANS using low power TFL 4 - 10 Watts, short pulse mode or Group 3: URS with FANS using high power TFL 16 - 24 Watts, short pulse mode. The ureteroscopic procedures are performed in general anaesthesia using a standardised technique. All patients are followed up with a low dose CT scan 3 months post endoscopically to assess stone free status as well as a consultation at the outpatient clinic. Results and data for the three randomisation groups are compared according to the aims of the study.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Aug 2026
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 28, 2026
CompletedFirst Posted
Study publicly available on registry
August 3, 2026
CompletedStudy Start
First participant enrolled
August 15, 2026
ExpectedPrimary Completion
Last participant's last visit for primary outcome
March 31, 2027
Study Completion
Last participant's last visit for all outcomes
June 30, 2027
August 3, 2026
July 1, 2026
8 months
July 28, 2026
July 28, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Stone free rate
Assessment of stone free status (or the presence of residual fragments) on low dose CT 3 months post endoscopically
3 months post endoscopically
Secondary Outcomes (4)
Operative time
During surgery (approximately 1 hour), registered immediately after surgery
Laser activation patterns: active laser time
During surgery (approximately 1 hour), registered immediately after surgery
Intraoperative complications
During surgery (approximately 1 hour), registered immediately after surgery
Postoperative complications
After surgery until 3 months post endoscopically
Other Outcomes (5)
Operative time, FANS low power vs FANS high power
During surgery (approximately 1 hour), registered immediately after surgery
Stone free rate, FANS low power vs FANS high power
3 months post endoscopically
Laser activation patterns: active laser time, FANS low power vs FANS high power
During surgery (approximately 1 hour), registered immediately after surgery
- +2 more other outcomes
Study Arms (3)
Group 1 - Sheathless URS, low power
EXPERIMENTALSheathless URS using low power laser settings (4-6W), short pulse: 0.4 - 0.5J at 10 or 20Hz, or 0.6 - 0.8J at 10Hz
Group 2 - FANS, low power
EXPERIMENTALURS with FANS using low power laser settings (4-6W), short pulse: 0.4 - 0.5J at 10 or 20Hz, or 0.6 - 0.8J at 10Hz
Group 3 - FANS, high power
EXPERIMENTALURS with FANS using high laser power (16-24W), short pulse: 0.4 - 0.5J at 40Hz, 0.6J at 30 - 40Hz, or 0.8J at 20 - 30Hz
Interventions
Sheathless URS using low laser power (4-6W), short pulse: 0.4 - 0.5J at 10 or 20Hz, or 0.6 - 0.8J at 10Hz. Standard start-up settings: 0.4J/10Hz (4W)
Sheathless URS using low laser power (4-6W), short pulse: 0.4 - 0.5J at 10 or 20Hz, or 0.6 - 0.8J at 10Hz. Standard start-up settings: 0.6J/10Hz (6W)
URS with FANS using high laser power (16-24W), short pulse: 0.4 - 0.5J at 40Hz, 0.6J at 30 - 40Hz, or 0.8J at 20 - 30Hz. Standard start-up settings: 0.4J/40Hz (16W)
Eligibility Criteria
You may qualify if:
- Patients ≥ 18 years scheduled for URS lithotripsy for renal stones, 8-25 mm, at the day surgery unit at Haukeland University Hospital, Akershus University Hospital and The Hospital of Vestfold
You may not qualify if:
- Concomitant ureteral stone
- Urinary diversion
- Active infection
- Untreated cancer in the upper urinary tract
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Haukeland University Hospitallead
- University Hospital, Akershuscollaborator
- The Hospital of Vestfoldcollaborator
Study Sites (1)
Haukeland University Hospital
Bergen, Vestland, 5021, Norway
Related Publications (2)
AEsoy MS, Juliebo-Jones P, Gjengsto P, Beisland C, Ulvik O. Watt's the difference? A randomised trial of high- vs low-power ureteroscopic thulium fibre laser lithotripsy. BJU Int. 2026 Mar;137(3):485-492. doi: 10.1111/bju.70123. Epub 2025 Dec 22.
PMID: 41429432BACKGROUNDUlvik O, AEsoy MS, Juliebo-Jones P, Gjengsto P, Beisland C. Thulium Fibre Laser versus Holmium:YAG for Ureteroscopic Lithotripsy: Outcomes from a Prospective Randomised Clinical Trial. Eur Urol. 2022 Jul;82(1):73-79. doi: 10.1016/j.eururo.2022.02.027. Epub 2022 Mar 14.
PMID: 35300888BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Øyvind Ulvik
Haukeland University Hospital
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Masking Details
- Stone free status is assessed on low dose CT 3 months post endoscopically by an outcome assessor blinded to the randomisation.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 28, 2026
First Posted
August 3, 2026
Study Start (Estimated)
August 15, 2026
Primary Completion (Estimated)
March 31, 2027
Study Completion (Estimated)
June 30, 2027
Last Updated
August 3, 2026
Record last verified: 2026-07
Data Sharing
- IPD Sharing
- Will not share
Not allowed according to national regulations and ethical approval.